Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chu Van Nguyen MD, PhD"'
Autor:
Kien Hung Do MD, PhD, Tai Van Nguyen MD, Trang Thu Hoang MD, Thanh Cam Do MD, Phuong Dac Phan MD, Chu Van Nguyen MD, PhD, Quang Le Van MD, PhD
Publikováno v:
Cancer Control, Vol 31 (2024)
Background The standard treatment for localized osteosarcoma is neoadjuvant chemotherapy before surgery, followed by adjuvant chemotherapy. Our aim was to report the rate of histopathological response to neoadjuvant chemotherapy for the treatment of
Externí odkaz:
https://doaj.org/article/29ba5e7d9d49458ba2114978ebc6e7da
Autor:
Huyen Thi Phung MD, PhD, Chu Van Nguyen MD, PhD, Nhung Thi Mai MB, Ha Thi Ngoc Vu MD, Khoa Hong Pham MD, PhD, Giang Le Tran MB
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Background: The androgen receptor (AR) has recently emerged as a useful marker for the more favorable prognosis and better outcomes among women with estrogen receptor (ER) + ve breast cancer (BC) and the further refinement of BC subtype. Furthermore,
Externí odkaz:
https://doaj.org/article/a601d5b84f2e4a2eb7e62a897b4f31ad
Autor:
Chu Van Nguyen MD, PhD, Quang Tien Nguyen MD, PhD, Ha Thi Ngoc Vu MD, Huyen Thi Phung MD, PhD, Khoa Hong Pham MD, PhD, Roanh Dinh Le MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Background: Aberrant of p53 and Bcl2 genes cause changes in the quantity and quality of their proteins and contribute to the pathogenesis of some cancer types including breast cancer. Expression of p53 and Bcl2 were associated to adverse clinical out
Externí odkaz:
https://doaj.org/article/c920ec10558f43648a9ed8df698484ff
Autor:
Tu Van Dao MD, PhD, Chu Van Nguyen MD, PhD, Quang Tien Nguyen MD, PhD, Ha Thi Ngoc Vu MD, Huyen Thi Phung MD, PhD, Oanh Thi Bui Pharm, MPH, Dung Khac Nguyen Pharm, PhD, Bang Viet Luong MD, Thuan Van Tran MD, PhD
Publikováno v:
Cancer Control, Vol 27 (2020)
Background: Tumor budding (Bd) has been demonstrated to be a promising prognostic factor in many carcinomas and in gastric cancer. It may represent an optimal additional parameter that is helpful for risk stratification in gastric adenocarcinoma. Hen
Externí odkaz:
https://doaj.org/article/9b04b1bfa545478e9500068b2e6af202
Autor:
Dao, Tu Van, Nguyen, Chu Van, Nguyen, Quang Tien, Vu, Ha Thi Ngoc, Phung, Huyen Thi, Bui, Oanh Thi, Nguyen, Dung Khac, Luong, Bang Viet, Tran, Thuan Van
Publikováno v:
Cancer Control: Journal of the Moffitt Cancer Center; 11/2/2020, p1-12, 12p